These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1829974)

  • 21. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM; Bruno JP
    Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro.
    Momiyama T; Todo N; Sasa M
    Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of D2 receptor agonist-induced inhibition by D1 receptor agonist in the ventral tegmental area.
    Momiyama T; Sasa M; Takaori S
    Br J Pharmacol; 1993 Oct; 110(2):713-8. PubMed ID: 7902179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rotation in response to selective dopamine receptor agonists in rats with electrolytic substantia nigra lesions.
    Asin KE; Bednarz L; Montana W
    Life Sci; 1990; 46(25):1817-23. PubMed ID: 1972973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study.
    Sesack SR; Bunney BS
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1323-33. PubMed ID: 2564893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine D1 receptor modulation of pilocarpine-induced convulsions.
    Barone P; Parashos SA; Palma V; Marin C; Campanella G; Chase TN
    Neuroscience; 1990; 34(1):209-17. PubMed ID: 2139189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeated stimulation of dopamine D1 receptors enhances the effects of dopamine receptor agonists.
    White FJ; Hu XT; Brooderson RJ
    Eur J Pharmacol; 1990 Dec; 191(3):497-9. PubMed ID: 1982272
    [No Abstract]   [Full Text] [Related]  

  • 29. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum.
    Napier TC; Maslowski-Cobuzzi RJ
    Synapse; 1994 Jul; 17(3):160-6. PubMed ID: 7974198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low level lead exposure increases sensitivity to the stimulus properties of dopamine D1 and D2 agonists.
    Cory-Slechta DA; Widzowski DV
    Brain Res; 1991 Jul; 553(1):65-74. PubMed ID: 1681979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of (+)-4-propyl-9-hydroxynaphthoxazine on midbrain dopamine neurons: an electrophysiological study.
    Kelland MD; Freeman AS; LeWitt PA; Chiodo LA
    J Pharmacol Exp Ther; 1990 Oct; 255(1):276-84. PubMed ID: 1976800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. D-1 dopamine receptors and arousal.
    Ongini E
    Adv Exp Med Biol; 1988; 235():169-78. PubMed ID: 2976250
    [No Abstract]   [Full Text] [Related]  

  • 33. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
    Zhou LW; Qin ZH; Weiss B
    Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.
    Jiang HK; McGinty JF; Hong JS
    Brain Res; 1990 Jan; 507(1):57-64. PubMed ID: 1967976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of D1 and D2 dopamine receptor agonists on substantia nigra pars reticulata neurons.
    Waszczak BL
    Brain Res; 1990 Apr; 513(1):125-35. PubMed ID: 2140951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
    Turski WA; Cavalheiro EA; Ikonomidou C; Bortolotto ZA; Klockgether T; Turski L
    Synapse; 1990; 5(2):113-9. PubMed ID: 2137942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemispheric asymmetry in behavioral response to D1 and D2 receptor agonists in the nucleus accumbens.
    Belcheva I; Bryer JB; Starkstein SE; Honig M; Moran TH; Robinson RG
    Brain Res; 1990 Nov; 533(2):286-91. PubMed ID: 1981170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
    DeBoer P; Abercrombie ED
    J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of D1 and D2 dopamine receptors in the expression of dopamine agonist induced behaviors.
    Braun AR; Barone P; Chase TN
    Adv Exp Med Biol; 1986; 204():151-66. PubMed ID: 2947426
    [No Abstract]   [Full Text] [Related]  

  • 40. One year of continuous treatment with haloperidol or clozapine fails to induce a hypersensitive response of caudate putamen neurons to dopamine D1 and D2 receptor agonists.
    Jiang LH; Kasser RJ; Altar CA; Wang RY
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1198-205. PubMed ID: 1972751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.